Altered mitochondrial metabolism in the insulin‐resistant heart

M Makrecka‐Kuka, E Liepinsh, AJ Murray… - Acta …, 2020 - Wiley Online Library
Obesity‐induced insulin resistance and type 2 diabetes mellitus can ultimately result in
various complications, including diabetic cardiomyopathy. In this case, cardiac dysfunction is …

Mitochondrial dysfunction in atrial fibrillation—Mechanisms and pharmacological interventions

P Muszyński, TA Bonda - Journal of Clinical Medicine, 2021 - mdpi.com
Despite the enormous progress in the treatment of atrial fibrillation, mainly with the use of
invasive techniques, many questions remain unanswered regarding the pathomechanism of …

Functional analysis of molecular and pharmacological modulators of mitochondrial fatty acid oxidation

Y Ma, W Wang, T Devarakonda, H Zhou, XY Wang… - Scientific reports, 2020 - nature.com
Fatty acid oxidation (FAO) is a key bioenergetic pathway often dysregulated in diseases. The
current knowledge on FAO regulators in mammalian cells is limited and sometimes …

Disturbed fatty acid oxidation, endoplasmic reticulum stress, and apoptosis in left ventricle of patients with type 2 diabetes

M Ljubkovic, M Gressette, C Bulat, M Cavar… - Diabetes, 2019 - Am Diabetes Assoc
Chronic heart failure is a common complication in patients with type 2 diabetes mellitus
(T2DM). T2DM is associated with disturbed metabolism of fat, which can result in excessive …

Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs

C Oyarce, A Vizcaino-Castro, S Chen, A Boerma… - …, 2021 - Taylor & Francis
ABSTRACT M2-like tumor-associated macrophages promote tumor progression by
establishing an immunosuppressive tumor microenvironment. The phenotype and activity of …

The impact of trimetazidine on cardiac fibrosis, inflammation, and function in ischemic cardiomyopathy patients

NM El-Khodary, AI Ghoneim, AA El-Tayaar… - … drugs and therapy, 2023 - Springer
Background Previous studies have shown that Trimetazidine (TMZ) improves vascular
endothelial function and reduces the inflammatory process progression. However, limited …

Targeting mitochondria in cardiovascular diseases

F SG Silva, RF Simoes, R Couto… - Current pharmaceutical …, 2016 - ingentaconnect.com
Background: Cardiovascular diseases (CVDs) are one of the main factors responsible for
human morbidity and mortality. Since mitochondria play a critical role in the regulation of …

BSCL2/Seipin deficiency in hearts causes cardiac energy deficit and dysfunction via inducing excessive lipid catabolism

H Zhou, J Li, H Su, J Li, TA Lydic… - Clinical and …, 2022 - Wiley Online Library
Background Heart failure (HF) is one of the leading causes of death worldwide and is
associated with cardiac metabolic perturbations. Human Type 2 Berardinelli‐Seip …

Trimetazidine Improves Mitochondrial Dysfunction in SOD1G93A Cellular Models of Amyotrophic Lateral Sclerosis through Autophagy Activation

I Salvatori, V Nesci, A Spalloni, V Marabitti… - International Journal of …, 2024 - mdpi.com
Amyotrophic Lateral Sclerosis (ALS) is considered the prototype of motor neuron disease,
characterized by motor neuron loss and muscle waste. A well-established pathogenic …

Перспективы применения антигипоксантов в лечении митохондриальных дисфункций

ВЕ Новиков, ОС Левченкова… - Вестник Смоленской …, 2020 - cyberleninka.ru
Цель. Анализ эффективности лекарственных препаратов с преимущественно
антигипоксическим действием в лечении митохондриальных дисфункций (МД) …